These observations strongly suggest a role for TrkB.T1 in the pathophysiology of ALS and alternative ways to activate TrkB.FL may be needed to overcome the insufficient or defective TrkB signaling. The gene discussed is NTRK2; the disease is amyotrophic lateral sclerosis.